Cubist Pharmaceuticals (CBST) agrees to acquire Adolor (ADLR) for ~$190M in cash, or...

|By:, SA News Editor

Cubist Pharmaceuticals (CBST) agrees to acquire Adolor (ADLR) for ~$190M in cash, or $4.25/share, and will make an additional contigent payment of up to $4.25/share for certain milestones related to Adolor's ADL5945, a potential treatment for chronic opioid induced constipation. ADLR +134.9% premarket.